logo
logo
Sign in

The Fc protein and glyco-engineered antibodies market

avatar
ella turner
The Fc protein and glyco-engineered antibodies market

London

 

Roots Analysis has announced the addition ofFc Protein and Glyco-engineered Antibodies Market, 2021-2030” report to its list of offerings.

 

Over time, a substantial body of evidence has validated the therapeutic applications of Fc engineering platforms; Fc modified antibodies have shown to augment the various immune effector functions, such as antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), antibody-dependent cellular phagocytosis (ADCP) activity and / or the half-life of the molecule

 

To order this 250+ page report, which features 100+ figures and 110+ tables, please visit https://www.rootsanalysis.com/reports/fc-protein-engineered-and-glycoengineered-antibodies-market.html

 

Key Market Insights

 

The Fc engineered antibodies pipeline features more than 125 marketed drugs / drug development programs

Around 15% Fc protein and glyco-engineered antibodies are marketed, while close to 75% are being evaluated in different phases of clinical trials and 10% in preclinical studies. Examples of marketed Fc engineered antibodies include Gazvya®, Imfinzi®, MONJUVI® and Skyrizi®.  

  

Close to 6,500 patents have been filed / granted for Fc protein and glyco-engineered antibodies, since 2016

Around 30% of these intellectual property documents were filed / granted in the Asia-Pacific; with maximum number of patents filed in Australia. This is followed by North America (32%) and Europe (23%). Leading industry players (in terms of the size of intellectual property portfolio) include Roche, Janssen, Novartis, Genentech, Amgen, MacroGenics and Genmab.

 


To request a sample copy / brochure of this report, please visit this https://www.rootsanalysis.com/reports/fc-protein-engineered-and-glycoengineered-antibodies-market/request-sample.html

 

Key Questions Answered

§ Who are the leading industry and non-industry players engaged in the development of Fc protein and glyco-engineered antibodies?

§ Which are the key disease indications being targeted by Fc engineered antibodies?

§ Which partnership models are commonly adopted by stakeholders engaged in this domain?

§ Which geographies are the most active in conducting clinical trials on Fc protein and glyco-engineered antibodies? 

§ Which are the leading administering institutes supporting the research related to Fc protein and glyco-engineered antibodies? 

§ How has the intellectual property landscape in this market evolved over the years?

§ Which key factors are likely to influence the evolution of this market?

§ How is the current and future market opportunity likely to be distributed across key market segments?

 

For additional details, please visit 

https://www.rootsanalysis.com/reports/fc-protein-engineered-and-glycoengineered-antibodies-market.html

or email [email protected]

                                                                                                                                              

 

You may also be interested in the following titles:

1.     TIL-based Therapies Market, 2021-2030

2.     TCR-based Therapies Market, 2021-2030

3.      Peptide Therapeutics Market, 2021-2030

 

                       

Contact:

Ben Johnson

+1 (415) 800 3415

[email protected]

 

collect
0
avatar
ella turner
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more